Immix Biopharma, Inc.

Nasdaq:IMMX

Pharmaceutical Preparations·LOS ANGELES, CA

CEO

Rachman Ilya M

CFO

Morris Gabriel S

Financials

18 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/7/25	→
10-Q	Q2 2025	6/30/25	8/8/25	→
10-Q/A	Q1 2025	3/31/25	5/19/25	→
10-K/A	FY 2024	12/31/24	5/19/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/25/25	→
↓

News (8-K)

26 shown

Filed	Type	Description
12/8/25	Agreement	Entry into a Material Definitive Agreement	→
12/8/25	Reg FD	Regulation FD Disclosure	→
11/26/25	Other	Other Events	→
9/8/25	Exec Change	Entry into a Material Definitive Agreement	→
6/23/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/3/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

27 shown

Filed	Form	Description
1/9/26	S-3	S-3	→
12/8/25	424B5	424B5	→
12/8/25	FWP	FWP	→
10/6/25	S-3	S-3	→
6/3/25	424B5	424B5	→
5/19/25	ARS	ARS	→
↓

Filing History(206 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G

Feb 17, 2026

0001104659-26-016248

—

12.8 KB

SCHEDULE 13G

Feb 17, 2026

0001274173-26-000078

—

12.0 KB

EFFECT

Jan 22, 2026

9999999995-26-000261

—

1.7 KB

CORRESP

Jan 16, 2026

0001493152-26-002680

—

52.0 KB

UPLOAD

Jan 16, 2026

0000000000-26-000603

—

39.1 KB

S-3

Jan 9, 2026

0001493152-26-001159S-3

—

1.7 MB

Dec 11, 2025

0001493152-25-0273294

Nov 21, 2025

7.0 KB

Dec 10, 2025

0001493152-25-0271094

Dec 10, 2025

4.5 KB

Dec 10, 2025

0001493152-25-0271074

Dec 8, 2025

12.3 KB

8-K

Dec 8, 2025

0001493152-25-0266978-K

Dec 7, 2025

635.6 KB

424B5

Dec 8, 2025

0001493152-25-026694424B5

—

899.2 KB

8-K

Dec 8, 2025

0001493152-25-0265008-K

Dec 7, 2025

236.6 KB

FWP

Dec 8, 2025

0001493152-25-026497FWP

—

34.9 KB

EFFECT

Dec 1, 2025

9999999995-25-003437

—

1.7 KB

8-K

Nov 26, 2025

0001493152-25-0251828-K

Nov 26, 2025

209.2 KB

10-Q

Nov 7, 2025

0001493152-25-02132510-Q

Sep 30, 2025

5.8 MB

S-3

Oct 6, 2025

0001493152-25-016975S-3

—

470.4 KB

Sep 17, 2025

0001493152-25-013919

Sep 17, 2025

4.9 KB

Sep 17, 2025

0001493152-25-013918

Sep 16, 2025

6.7 KB

Sep 17, 2025

0001493152-25-013834

Sep 8, 2025

6.8 KB

8-K

Sep 8, 2025

0001493152-25-0128048-K

Sep 5, 2025

752.5 KB

10-Q

Aug 8, 2025

0001641172-25-02282910-Q

Jun 30, 2025

5.7 MB

8-K

Jun 23, 2025

0001641172-25-0161208-K

Jun 20, 2025

207.4 KB

Jun 23, 2025

0001641172-25-016115

Jun 20, 2025

7.1 KB

Jun 23, 2025

0001641172-25-0161144

Jun 20, 2025

8.2 KB

25 filings shown

Filed	Form	Description
5/19/25	DEFA14A	DEFA14A	→
5/5/25	DEFA14A	DEFA14A	→
4/30/25	DEF 14A	DEF 14A	→
5/21/24	DEFA14A	DEFA14A	→
4/29/24	DEF 14A	DEF 14A	→
4/25/23	DEFA14A	DEFA14A	→
↓

Immix Biopharma, Inc.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(206 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/11/25	4	4	→
12/10/25	4	4	→
12/10/25	4	4	→
9/17/25	4	4	→
9/17/25	4	4	→
9/17/25	3	3	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
1/22/26	EFFECT	EFFECT	→
12/1/25	EFFECT	EFFECT	→
1/29/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/20/24	D	D	→
↓